When it comes to managing your rheumatoid arthritis (RA), things can turn complicated pretty quickly. Trying to keep track of the pain (when, where, and how badly it hits), the many medicines you may ...
Urcosimod is currently being evaluated in a phase 2 trial evaluating it's efficacy and safety in adults with neuropathic corneal pain. OKYO Pharma has filed a Fast Track designation application with ...
Urcosimod ophthalmic solution (0.05% and 0.1%) is currently being evaluated in a phase 2 trial in patients aged 18 years and older with neuropathic corneal pain. The Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback